Table 2:

Vessel simulation parameters of a polymer-based TEVG informed by parameters described previously.^7,22

Tissue-Engineered Neovessel Properties
Initial volume fractions	${\mathrm{\Phi }}_0^{p1}$, ${\mathrm{\Phi }}_0^{p2}$, ${\mathrm{\Phi }}_0^{gnd}$	0.15, 0.05, 0.8
True mass densities	${\hat{\rho }}^{p1}$, ${\hat{\rho }}^{p2}$, ${\hat{\rho }}^{gnd}$	1230, 1530, 1050 kg/m3
Material parameters	$c^1$, $c^2$	2000000, 1000 kPa
Polymer degradation parameters	$k^{p1}$, $k^{p2}$, $k^{gnd}$	1/80, 1/10, 1/80 days
	${\zeta }^1$, ${\zeta }^2$	245,60
	${\gamma }^{p1}$, ${\gamma }^{p2}$	4,4
	${\epsilon }_{Rmin}^{gnd}$	0.10
	$s_d^{gnd}$	14 days
Inflammatory collagen parameters	$c_1^i,c_2^i$	80.88 kPa, 14.92
Inflammatory tissue production parameters	$K^i,{\delta }^i,{\beta }^i$	26.8196, 0.25, 5.0
Inflammatory tissue degradation parameter	$K^i$	26.8196, 0.25, 5.0